Ignite Creation Date:
2024-05-06 @ 3:09 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04530682
Status:
COMPLETED
Last Update Posted:
2024-04-30
First Post:
2020-07-27
Brief Title:
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs
Sponsor:
Organization:
University Hospital Montpellier
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Serum and plasma samples at baseline Serum samples at 0 6 12 and 24 months
Enrollment Count:
163
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 68171 |
Who Masked List: